flurbiprofen has been researched along with Neoplasm Metastasis in 4 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
Excerpt | Relevance | Reference |
---|---|---|
"In the present study, we have examined the antimetastatic effect of flurbiprofen, a nonsteroidal antiinflammatory drug, on spontaneous metastases formation in mice bearing Lewis lung carcinoma and these results were compared with effects of other inhibitors of platelet function (mopidamole, dipyridamole, pentoxifylline)." | 3.67 | Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors. ( Grimová, J; Kacerovská, H; Mamytbeková, A; Rezábek, K; Svobodová, J, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Leaper, DJ | 2 |
French, B | 1 |
Bennett, A | 2 |
Lokeshwar, BL | 1 |
Houston-Clark, HL | 1 |
Selzer, MG | 1 |
Block, NL | 1 |
Golub, LM | 1 |
Houghton, J | 1 |
Stamford, IF | 1 |
Mamytbeková, A | 1 |
Rezábek, K | 1 |
Kacerovská, H | 1 |
Grimová, J | 1 |
Svobodová, J | 1 |
4 other studies available for flurbiprofen and Neoplasm Metastasis
Article | Year |
---|---|
Reduction by flurbiprofen of primary tumor growth and local metastasis formation in mice.
Topics: Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Male; Mammary Neoplasms, Experimental; | 1980 |
Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Division; D | 1998 |
Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen.
Topics: Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Male; Mammary Neoplasms, Experimental; | 1979 |
Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.
Topics: Animals; Antineoplastic Agents; Dipyridamole; Flurbiprofen; Lung Neoplasms; Male; Mice; Mice, Inbred | 1986 |